This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Clinical and Demographic Characteristics of Participants in a Hepatitis C Treatment Trial in Rural Kentucky: How Policies Around Treatment Access May Impact Elimination Efforts in the United States

Link
View resource
Description
Examines characteristics and drug use patterns of the participants in the Kentucky Viral Hepatitis C Treatment (KeY Treat) trial, which focuses on improving access to direct acting antiviral (DAA) drugs to treat the hepatitis C virus (HCV). Discuses Medicaid policy related to DAA treatment of HCV in a rural, Appalachian community in Kentucky.
Author(s)
Jennifer R. Havens, Brittney D. Williams, Takako Schaninger, et al.
Citation
Journal of Rural Health, 42(1), e70128
Date
02/2026
Tagged as
Access · Appalachia · Illicit drug use · Infectious diseases · Medicaid · Policy · Statistics and data · Kentucky